Dietrich, L.; Kibler, M.; Matsushita, K.; Marchandot, B.; Trimaille, A.; Reydel, A.; Diop, B.; Truong, P.D.; Trung, A.M.; Trinh, A.;
et al. Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR. J. Clin. Med. 2022, 11, 212.
https://doi.org/10.3390/jcm11010212
AMA Style
Dietrich L, Kibler M, Matsushita K, Marchandot B, Trimaille A, Reydel A, Diop B, Truong PD, Trung AM, Trinh A,
et al. Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR. Journal of Clinical Medicine. 2022; 11(1):212.
https://doi.org/10.3390/jcm11010212
Chicago/Turabian Style
Dietrich, Laurent, Marion Kibler, Kensuke Matsushita, Benjamin Marchandot, Antonin Trimaille, Antje Reydel, Bamba Diop, Phi Dinh Truong, Anh Mai Trung, Annie Trinh,
and et al. 2022. "Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR" Journal of Clinical Medicine 11, no. 1: 212.
https://doi.org/10.3390/jcm11010212
APA Style
Dietrich, L., Kibler, M., Matsushita, K., Marchandot, B., Trimaille, A., Reydel, A., Diop, B., Truong, P. D., Trung, A. M., Trinh, A., Carmona, A., Hess, S., Jesel, L., Ohlmann, P., & Morel, O.
(2022). Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR. Journal of Clinical Medicine, 11(1), 212.
https://doi.org/10.3390/jcm11010212
